Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic combination risk for schizophrenia.
Oishi K, Niitsu T, Kanahara N, Hashimoto T, Komatsu H, Sasaki T, Takase M, Sato Y, Iyo M. Oishi K, et al. Among authors: niitsu t. Schizophr Res. 2020 Jan;215:473-474. doi: 10.1016/j.schres.2019.08.021. Epub 2019 Aug 30. Schizophr Res. 2020. PMID: 31477374 No abstract available.
Fluvoxamine improved cognitive impairments in a patient with schizophrenia.
Niitsu T, Shirayama Y, Fujisaki M, Hashimoto K, Iyo M. Niitsu T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1345-6. doi: 10.1016/j.pnpbp.2010.06.007. Epub 2010 Jun 19. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 20600473 No abstract available.
Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
Niitsu T, Shirayama Y, Matsuzawa D, Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Shiina A, Fukami G, Fujisaki M, Watanabe H, Nakazato M, Asano M, Kimura S, Hashimoto K, Iyo M. Niitsu T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1836-40. doi: 10.1016/j.pnpbp.2011.09.004. Epub 2011 Sep 10. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21930178
Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.
Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T, Shiina A, Hashimoto T, Kanahara N, Hasegawa T, Enohara M, Kimura A, Iyo M, Hashimoto K. Yoshida T, et al. Among authors: niitsu t. PLoS One. 2012;7(8):e42676. doi: 10.1371/journal.pone.0042676. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22880079 Free PMC article.
Strategy for treating selective serotonin reuptake inhibitor-resistant social anxiety disorder in the clinical setting: a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment.
Yoshinaga N, Niitsu T, Hanaoka H, Sato Y, Ohshima F, Matsuki S, Kobori O, Nakazato M, Nakagawa A, Iyo M, Shimizu E. Yoshinaga N, et al. Among authors: niitsu t. BMJ Open. 2013 Feb 13;3(2):e002242. doi: 10.1136/bmjopen-2012-002242. Print 2013. BMJ Open. 2013. PMID: 23408078 Free PMC article.
105 results